PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 257 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,239,975 | +13.3% | 148,500 | +80.4% | 0.00% | -20.0% |
| Q2 2023 | $1,094,590 | -1.2% | 82,300 | -14.0% | 0.01% | 0.0% |
| Q1 2023 | $1,108,206 | -99.8% | 95,700 | +14.7% | 0.01% | +25.0% |
| Q3 2022 | $484,531,000 | -23.6% | 83,468 | +169.3% | 0.00% | 0.0% |
| Q4 2021 | $634,260,000 | -59.5% | 31,000 | -49.4% | 0.00% | -63.6% |
| Q3 2021 | $1,566,215,000 | -44.5% | 61,300 | -24.0% | 0.01% | -52.2% |
| Q2 2021 | $2,822,079,000 | +49.2% | 80,700 | +42.1% | 0.02% | +9.5% |
| Q1 2021 | $1,892,008,000 | +359597.3% | 56,800 | -24.1% | 0.02% | +320.0% |
| Q2 2016 | $526,000 | +141.3% | 74,800 | +112.5% | 0.01% | +150.0% |
| Q2 2014 | $218,000 | – | 35,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |